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ABSTRACT  
The aim of the present work was to prepare hydrogel 
matrix tablets using crosslinked chitosan and hydroxyethyl 
cellulose (HEC) for controlled release of gabapentin. The chitosan 
was crosslinked with acetaldehyde and used for the preparation 
of hydrogel matrix tablets along with hydroxylethyl cellulose by 
wet granulation method. The samples were characterized by 
FTIR, DSC, TGA, XRD, SEM and evaluated drug content, swelling 
pattern and drug release. The matrix tablets were capable of 
releasing the drug for 24h depending upon the formulation 
variables. It was observed that as the concentration of HEC 
increased in the tablets, the drug release was also increased. On 
the other hand, as the crosslinking of chitosan was increased, 
the drug release was decreased. Drug release mechanism 
followed non-Fickian transport. This study demonstrated that 
the blend hydrogel matrix tablets of crosslinked chitosan and 
HEC could be a versatile drug delivery system for controlled 
release of gabapentin. 
 
Key words: tr crosslinked chitosan; hydroxyethyl cellulose; hydrogel 
tablets; controlled release; gabapentin 
 
INTRODUCTION 
Hydrogels are called as three 
dimensional hydrophilic networks which can 
absorb large amount of water or biological 
fluids; they are chemically stable and may 
undergo degradation and finally disintegrate 
and dissolve in water or biological fluids. To 
avoid this dissolution/degradation, a controlled 
reticulation (crosslinking) can be provided 
during the preparation of the hydrogels (Singh 
et al., 2006). Recently, much importance has 
been given to the preparation of hydrogels 
from natural polymers (Hoffman et al., 2002). 
Among natural polymers, chitosan, a linear 
polysaccharide, has been reported to be good 
for synthesizing hydrogels because of its greater 
crosslinking ability due to the presence of 
amino groups on its backbone (Ravi Kumar et 
al.,). The major limitation of chitosan in drug 
delivery is its poor water solubility and rapid 
swelling in acidic conditions that leads to burst 
release of drugs. To overcome these limitations, 
several modifications have been attempted such 
as crosslinking, preparation of derivatives etc. 
(Chen et al., 2004). Biodegradability and 
biocompatibility of chitosan  has prompted the 
researchers to explore it in a variety of areas 
such as medicine, drug delivery, tissue 
engineering, antimicrobial agents, textiles, 
chromatography, metal chelation, and other 
industrial as well as biomedical applications 
(Gong et al., 2000, Kim et al., 1992, Drury et al., 
2003, Zhao et al., 2003). Many methods have 
been reported for the crosslinking of chitosan, 
such as chemical crosslinking with 
glutaraldehyde, blocked diisocyanate (Lin-
Gibson et al., 2003) and with Mo (IV) 
polyoxyanions (Draget et al., 1992). Among all 
these, chemical crosslinking methods seem to 
be a better approach to improve the strength of 
hydrogels. 
The oral route of drug administration 
has received the most attention as it is 
uncomplicated, convenient and safer (Mutalik et 
al., 2008). Controlled release matrix tablets are 
among the most popular delivery systems for 
oral controlled release dosage forms. These 
matrix tablets are generally accepted because of 
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their advantages over conventional dosage 
forms. They show distinct modulation in drug 
release as a result of hydration of the 
constituent polymer, flexibility to obtain desired 
drug release profiles, cost effectiveness, patient 
compliance, providing a constant, prolonged, 
and uniform drug release and more important 
is acceptability by Food and Drug 
Administration (FDA). The swelling behavior 
and erosion of hydrogel matrix in aqueous 
media are very crucial in getting the desired 
drug release and are affected by the crosslinking 
of polymer and other formulation 
compositions (Pavithra et al., 2010). 
Gabapentin (GBP) is an analog of         
γ-aminobutyric acid (GABA), which is 
presently given as an adjunctive therapy for 
partial seizures with epilepsy and also for post 
herpetic neuralgia. GBP has a relatively short 
half-life of 5h that requires repeated dosing. 
The repeated administration of GBP may leads 
to non-compliance in epilepsy patients. Hence, 
it would be better, if GBP is given as a 
controlled release (CR) tablet, which may 
provide prolonged release with greater efficacy 
and a reduced incidence of adverse effects  
(Bryans et al., 1999). 
Hence, looking into the account of 
potential of chitosan, and GBP dosing, the 
present work was aimed to prepare matrix 
tablets using crosslinked chitosan and 
hydroxyethyl cellulose (HEC) for controlled 
release of GBP.   
 
MATERIALS AND METHODS 
Gabapentin (GBP) was obtained as a gift 
sample from Cipla Ltd. (Mumbai, India). 
Chitosan was procured from Vishu Aquatech, 
Madras, India. hydroxyethyl cellulose (HEC), 
acetaldehyde (AL), lactose, magnesium stearate, 
and starch were purchased from s d fine-
chemicals Ltd (Mumbai, India). Double distilled 
water was used throughout the study. All other 
chemicals were of analytical grade and procured 
form local laboratory chemicals suppliers and 
used without further purification.  
 
Crosslinking of chitosan with acetaldehyde 
A 2% w/v chitosan (CH) solution was 
prepared in 2% v/v aqueous acetic acid using a 
magnetic stirrer until the chitosan dissolved 
completely. To this polymeric solution, 
acetaldehyde (AL) (5%, 10%, 15% and 20% 
w/w of dry chitosan; which were designated as 
CHAL1, CHAL2, CHAL3 and CHAL4 
respectively), 0.5mL of 0.1N HCl were added 
and stirred for 1h at 50°C. After 1h, the 
reaction mixture was cooled to room 
temperature, excess quantity of acetone was 
added and the precipitated hydrogel was 
repeatedly washed with distilled water to 
remove any unreacted material. Further, it was 
dried at 40°C for 24h; powdered and stored in 
a well closed container (Kulkarni et al., 2005). 
 
Preparation of hydrogel matrix tablets  
The matrix tablets were prepared by 
conventional wet granulation method. 
Accurately weighed quantities of GBP, 
crosslinked chitosan (CHAL1, CHAL2, 
CHAL3 and CHAL4), HEC, and micro-
crystalline cellulose (MCC) were passed 
through sieve # 80 and mixed to get uniform 
mass. To this, sufficient amount of binding 
agent (starch paste 5 % w/v) was added. After 
required cohesiveness was attained, the mass 
was sieved through 22/44mesh. The granules 
were dried at 40°C for 12h and then kept in a 
desiccator for 12h at room temperature. The 
granules retained on 44 mesh were taken and 
mixed with 10% of fines (granules that passed 
through 44mesh), talc and magnesium stearates 
were added as glidant and lubricants 
respectively and then compressed into tablets 
using a rotary tablet compression machine 
(Karnavati Minipress I, Ahmedabad, India). 
The total weight of tablets was 500 mg which 
contain 100mg of GBP and other ingredients as 
summarized in table I. The granules were tested 
for pre-compression parameters like bulk 
density, tap density, packing ability and flow 
property. Finally, tablets were evaluated for 
weight variation, drug content, hardness, 
friability, equilibrium swelling and in vitro drug 
release. 
 
Fourier transform infrared (FTIR) 
spectroscopy 
The CH, CHAL4, GBP and physical 
mixture of GBP and other excipients were 
crushed with KBr to make pellets under 
hydraulic pressure of 600kg, and then the FTIR 
spectra were recorded between 4000 and 
400cm-1. 
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Differential scanning calorimetric (DSC) 
analysis 
The G2, G4, G5, G6 and G7 samples 
were taken in a sealed aluminum DSC pan and 
an empty aluminum pan was used as reference. 
The samples were heated in the range of 40-
300°C at a heating rate of 10°C/min under 
nitrogen atmosphere in a microcalorimeter 
(Perkin Elmer, Pyris 6 DSC, USA) and the 
thermograms were obtained.  
 
Thermogravimetric (TG) analysis  
The CH, CHAL1, CHAL2 and CHAL3 
samples were heated in the range of 20-600°C 
at a heating rate of 10°C/min under argon 
atmosphere using a microcalorimeter (Perkin 
Elmer, USA) and thermograms were obtained. 
 
X-Ray diffraction studies  
The XRD spectra of the samples G2, 
G4, G5, G6 and G7 were recorded using a 
Philips, PW-171, X-ray diffractometer with Cu-
NF filtered CuK radiation. Quartz was used 
as an internal standard for calibration. The X-
ray diffractometer was attached to a digital 
graphical assembly and computer with Cu-NF 
25 KV/20 mA tube as a CuK radiation 
source in the 2 range 0-80°. 
 
Drug content uniformity  
Tablets were randomly selected and kept 
in 100mL USP phosphate buffer of pH 7.4 at 
37°C for 12h. After 12h, tablets were crushed 
with glass rod, heated tenderly for 3h to take 
out the drug from hydrogel matrix and then 
centrifuged to separate the polymeric debris. 
The clear solution was subjected for drug 
content analysis using UV-visible spectrophoto-
meter (Model Pharmaspec UV-1700, Shimadzu, 
Japan) at 215nm.  
 
Equilibrium swelling study 
The equilibrium swelling of the hydrogel 
tablets was performed by mass measurement. 
Accurately weighed tablet was kept in with 
100mL phosphate buffer solutions of pH 1.2 
and 7.4 at 37°C for 8h. The tablets were taken 
out after 8 h and blotted carefully to remove 
surface liquid. The swollen tablets were 
weighed again using the electronic 
microbalance (Shimadzu, Japan) and the 
swelling ratio was calculated.  
In-vitro drug release  
The in-vitro drug release study was carried 
out using a USP-23 rotating dissolution tester. 
GBP release from the tablets was studied in 
900mL acidic medium (pH 1.2) for 2h and in 
alkaline medium (pH 7.4 phosphate buffer) till 
end of the study at 37.0±0.5°C and 50rpm 
speed. At different time intervals, 5mL aliquots 
were taken out and replaced with the same 
volume of fresh solution. The amount of drug 
released was analyzed using UV-visible 
spectrophotometer at 215nm. 
Further, release data were fitted to 
various mathematical models such as Zero 
order release kinetics, Higuchi model, and 
Korsmeyer-Peppas models to find which model 
is the best fit for the release profile obtained. 
 
Scanning electron microscopy (SEM) 
The SEM analysis was carried out by 
mounting the samples on the stub using double 
sided adhesive tape and sputter coated with 
platinum using a sputter coater (Edward S 150, 
UK). The coated tablets were observed under 
SEM (JEOL, JSM-6360, Kyoto, Japan) at room 
temperature. The acceleration voltage used was 
10 kV with the secondary electron image as a 
detector.  
 
RESULTS AND DISCUSSION 
The hydrogel based matrix tablets of 
crosslinked chitosan (CHAL1, CHAL2, 
CHAL3 and CHAL4) and HEC blend were 
prepared and evaluated for controlled release of 
GBP. There are number of crosslinking agents 
that can crosslink chitosan. Among them, 
aldehydes are the commonly used as cross-
linking agents because they are inexpensive and 
easily available. The crosslinking ability and 
water retention efficiency of hydrogel depends 
on the crosslinking agent. The polymers having 
hydroxyl group need drastic conditions (low 
pH, high temperature, etc) for crosslinking 
reactions with aldehydes whereas, polymers 
having amine groups can be crosslinked 
aldehydes under mild conditions through Schiff 
bases reactions.  
In our earlier study, we reported the use 
of chitosan hydrogel prepared by different 
crosslinking agents like dextrose, urea-
formaldehyde, sodium tripolyphosphate          
and acetaldehyde for controlled release of GBP 
Narasimha S. Managoli 
Volume 25 Issue 3 (2014) 167 
(Managoli et al., 2012). Now, in this work, we 
are reporting the use of chitosan hydrogel 
prepared by crosslinking with acetaldehyde with 
a blend of HEC for controlled release of GBP. 
Chitosan hydrogels were prepared by 
crosslinking with AL, where the chitosan 
undergoes reaction with AL through Schiff 
base mechanism under mild conditions 
(Hemant et al., 2010). 
 
FTIR analysis 
The FTIR spectra of CH and CHAL2 
are given in Figure 1 (A) and (B) respectively. 
In case of CH, the peak at 3341 cm–1 is 
assigned for the stretching vibrations of 
hydroxyl and amino groups, the peak at 2887 
cm–1 is due to stretching vibrations of –CH 
groups, the peak at 1602cm–1 is due to the 
amino groups, and the peak at 1074cm–1 is due 
to the ether group. While in case of CHAL2, 
peak at 3340 cm–1 is assigned for the stretching 
vibrations of hydroxyl groups, the peak at 2876 
is due to stretching vibrations of –CH groups, 
the peak at 1654cm–1 is due to carbonyl 
stretching vibration of acetamide group, peak at 
1598 cm–1 due to imine bonds (C=N) formed 
by crosslinking reaction between the amino 
groups of chitosan and aldehyde groups of 
acetaldehyde. This peak confirms the formation 
of Schiff base after the crosslinking reaction. 
The stronger peak at 1085cm–1 is assigned to 
ether group which was shifted slightly from 
1074 to 1085 cm–1, this indicates the creation of 
a new open chain ether linkages in the crossed 
linked chitosan.  
Table I Composition of hydrogel matrix tablets 
 
Ingredients (mg) G1 G2 G3 G4 G5 G6 G7 
GBP 100 100 100 100 100 100 150 
CHAL1 150 150 150 0 0 0 0 
CHAL2 0 0 0 150 0 0 0 
CHAL3 0 0 0 0 150 0 0 
CHAL4 0 0 0 0 0 150 150 
HEC 50 100 150 100 100 100 100 
MCC 185 135 85 135 135 135 85 
Talc 10 10 10 10 10 10 10 
Magnesium stearate 5 5 5 5 5 5 5 
 
 
 
 
 
 
Figure 1. FTIR spectra of CH (A) and CHAL3 (B), FTIR spectra of GBP (C) and physical mixture 
of GBP and other excipients (D) 
 
Controlled Release of Gabapentin 
Volume 25 Issue 3 (2014) 168 
Figure 1 (C) and (D) depicts the FTIR 
spectra of GBP and physical mixture of GBP 
and other excipients respectively. The peaks at 
2923 and 2860cm-1 are due to NH3+  stretching 
vibrations, however there was no peak 
absorption in the usual -NH stretching regions 
(3500-3300cm-1). The peak at 2148 cm–1 is due 
to the distinct side chain and/or C-N stretching 
vibrations of GBP polymorphs. The peaks at 
1614 and 1542cm–1 could be assigned as the 
ionized asymmetric carboxylate and NH3+ 
deformation vibration. The peaks at 1474, 
1455, 1399, 1300cm–1 are corresponded also to 
the asymmetric carboxylate band and/or CH2 
deformation band.  Whereas, in the spectra of 
physical mixture of GBP and other excipients, 
the same characteristics peaks related to GBP 
were noticed with slight variations. This 
confirms the compatibility of GBP in the 
formulation. 
 
DSC analysis 
The DSC thermograms are shown in 
Figure 2. G2, G4, G5, G6 and G7 have shown 
endothermic peaks at 110.86, 115.52, 118.50, 
120.78 and 116.55°C respectively. This may due 
to the evaporation of associated water from the 
hydrogel matrix. While, the second 
endothermic peaks at 174.50, 176.13, 178.50, 
180.17 and 175.39°C may be related to the 
decomposition of the hydrogel matrix. In all 
the hydrogels, a shift in endothermic peaks was 
observed towards higher temperature. The 
order of endothermic peaks was G6 > G5 > 
G4 > G2. This shift in endothermic peak 
towards higher temperature could be due to the 
formation of stronger hydrogel network as a 
result of crosslinking. While in case of G7, the 
endothermic peak was shifted to lower 
temperature quite relatively, which may be due 
to the excess drug loading that looses the 
strength of the hydrogel matrix. 
 
TG analysis 
The TGA thermograms of CH, CHAL2, 
CHAL3 and CHAL4 are shown in figure 3. In 
case of CH (A), weight loss of 10.88% up to 
180°C was observed and is due to loss of 
associated water present in the polymer 
network and above 300°C it started 
decomposing, attributing to the degradation of 
polymer network, and weight loss reached a 
value of 100% at 500oC. The weight loss in case 
of CHAL2 (B) was 13.78% up to 160°C, due to 
the loss of water present in the polymer and 
further, weight loss reached a value of 72% at 
600°C, due to decomposition of polymer 
matrix. Similar pattern was observed with 
CHAL3 (C), with an initial weight loss of 
12.91% at 140°C and it reached value of 67% at  
 
 
 
 
 
 
Figure 2. DSC thermograms of G2 (A), G4 (B), G5 (C), G6 (D) and G7 (E) 
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600°C. Whereas, CHAL4 (D) showed an initial 
weight loss of 13.07% at 125°C and finally it 
reached a value of 64% at 600°C. From this 
study, it can be said that the thermal stability 
was in the order of CHAL4 > CHAL3 > 
CHAL2 > CH. This increase in thermal 
stability indicates the formation of stronger 
hydrogel network as a result of crosslinking. 
 
X-ray diffraction studies  
The XRD studies are useful to examine 
the crystallinity of the polymer as crystallinity 
increases with stiffer polymer network. The X-
ray diffractograms of formulations G2, G4, G5, 
G6 and G7 are presented in figure 4. All the 
samples have shown peaks between 2θ of 15° 
and 25° due to the crystallinity. The percentage 
crystallinity was 7.6%, 8.6%, 9.5%, 11.9% and 
11.7% for G2, G4, G5, G6 and G7 
respectively. The crystallinity was in the order 
of G6 > G7 > G5 > G4 > G2.  This order of 
crystallinity, consistent with the results of  DSC  
and TGA, which indicates that the crystallinity 
increases with crosslinking and that, may be 
attributed to increased stiffness of the hydrogel 
network.  
 
Evaluation of tablets 
The results obtained from evaluation of 
granules advocates that the granules have good 
flow properties with an angle of repose values 
less than 35o. A good packing ability of the 
granules was also indicated by Carr’s 
compressibility index and Hausner ratio since 
the values were in the range of 12.19 to 15.21 
and 1.122 to 1.152 respectively. The weight and 
drug contents of all the tablets were within the 
range of 502mg to 509mg and 95.50% to 
98.76% respectively and were found to be 
within the specified range. The hardness and 
friability were in the range of 5.3 to 6.0kg/cm2 
and 0.21% to 0.86% respectively, indicating the 
sufficient mechanical strength of the prepared 
hydrogel tablets.  
 
 
Figure 3. TGA thermograms of CH (A), CHAL2 (B), CHAL3 (C) and CHAL4 (D). 
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It was observed from the results of 
equilibrium swelling study that the swelling of 
hydrogel tablets depends upon the crosslinking 
of chitosan and concentration of HEC. As the 
amount of HEC was increased, the swelling of 
tablets was increased, which may be due to 
decreased stiffness of the hydrogel network. 
On the other hand, as the crosslinking of 
chitosan was increased, the swelling was 
decreased due to increased stiffness of network 
as a result of increased crosslink density 
(Kulkarni et al., 2011, Boppana et al., 2010). The 
swelling of hydrogel tablets was in the order G3 
> G2 > G1 > G4 > G5 > G7 > G6 and this is 
in agreement with the results of XRD, DSC 
and TGA. As the stiffness decreases swelling is 
expected to increase. We also noticed that the 
swelling  of  the  hydrogel  tablets was higher in  
 
 
  
 
 
 
Figure 4. X-ray diffractograms of G2 (A), G4 (B), G5 (C), G6 (D) and G7 (E). 
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   Figure 5. Drug release profiles of hydrogel matrix tablets 
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the solution of pH 1.2 as compared to the 
swelling in the solution of pH 7.4. It may be 
due to hydration of cations, formed by basic 
amino groups of chitosan under acidic 
condition.     
The drug release behaviour of hydrogel 
tablets is shown in igure 5. The tablets have 
shown drug release up to 24 h depending upon 
the formulation variables. The crosslinking of 
chitosan and amount of HEC directly affected 
of the drug release rate. As the amount of HEC 
 
 
* Before dissolution testing. ** After dissolution testing. 
 
Figure 6. SEM photomicrographs of hydrogel matrix tablets G2 (A), G4 (B), 
G5 (C) and G6 (D) before (*) and after (**) the dissolution studies.    
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was increased, the drug release rate from the 
tablets was increased; which can be attributed 
to increased swelling of the hydrogel network. 
On the other hand, as the crosslinking of 
chitosan was increased, we noticed decreased 
drug release. This could be due to the 
formation of stiffer hydrogel matrix at higher 
crosslink densities by decreasing the free 
volume of the matrix, thereby reducing the 
movement of drug molecules through the 
polymer network (More et al., 2010, Kulkarni et 
al., 2012). It was also noticed that the increase 
in initial drug loading increased the drug 
release. The drug release rate from the hydrogel 
tablets was in the order G3 > G2 > G1 > G4 
> G5 > G7 > G6, this order is also supported 
by XRD, DSC and TGA results. 
The drug release data was fitted to the 
following empirical equation (Ritger et al., 1997) 
to calculate the mechanism of drug release:  
nKt
M
Mt


……………(1) 
where Mt is the amount of drug released  
at time t, M is the total amount of drug loaded, 
K is constant and n values are the indication of 
the type of release mechanism. The calculated n 
values were in the range of 0.52 to 0.68. The n 
values were dependent on crosslinking of 
chitosan and amount HEC; as the amount of 
HEC was increased, the n values were 
decreased and as crosslinking of chitosan was 
increased, the n values were increased. This 
suggests that the mechanism of drug release 
from hydrogel tablets follows non-Fickian 
transport (Ritger et al., 1997).  
 
SEM results 
The surface morphology of the hydrogel 
tablets before and after the dissolution testing 
was studied using SEM analysis and are shown 
in Figure 6. The surface of the hydrogel tablets 
before drug release testing was smooth and 
uniform. While, after the drug release study, the 
surface of the tablets has become porous and 
dense with some polymeric erosion. This 
indicates that the hydrogel network has 
undergone swelling and drug might have 
diffused out through the matrix by polymer 
chain relaxation and erosion. 
 
 
CONCLUSIONS 
The hydrogel based matrix tablets of 
cross-linked chitosan and HEC blend were 
prepared and evaluated for controlled release of 
GBP. The weight and drug contents of all the 
tablets were found to be uniform. The hardness 
and friability were within specified range. The 
matrix tablets were competent to release the 
drug for 24 h depending upon the formulation 
variables. As the concentration of HEC was 
increased in the tablets, the drug release was 
also increased. This may be due to decreased 
stiffness of the hydrogel matrix. On the other 
hand, as the crosslinking of chitosan was 
increased, the drug release was decreased, 
which may be due to increased stiffness of the 
matrix. Drug release mechanism followed non-
Fickian transport. This study demonstrated that 
the blend hydrogel matrix of crosslinked 
chitosan and HEC could be a versatile drug 
delivery system for controlled release of GBP. 
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